By Dr Jana Stojanova

Conference Papers

Gatault P; Lajoie L; Stojanova J; Marquet P; Thibault G, 2020, 'The FcγRIIIa-158 VV Genotype Increased the Risk of Post-Transplant Lymphoproliferative Disorder in T-Cell Depleted Kidney Transplant Recipients', in AMERICAN JOURNAL OF TRANSPLANTATION, WILEY, ELECTR NETWORK, pp. 435 - 435, presented at American Transplant Congress (ATC), ELECTR NETWORK, 30 May 2020 - 01 June 2020

Pouche L; Koikta M; Woillard J; Villeneuve C; Stojanova J; Monchaud C; Essig M; Kamar N; Merville P; Gandia P; Bouchet S; Le Meur Y; Petersen B; Marquet P; Picard N, 2015, 'Genetic polymorphisms of the calcineurin pathway and their implication in renal transplant patient outcomes', in FUNDAMENTAL & CLINICAL PHARMACOLOGY, WILEY-BLACKWELL, pp. 11 - 11

Pouche L; Koitka M; Woillard JB; Villeneuve C; Stojanova J; Monchaud C; Essig M; Rerolle JP; Kamar N; Rostaing L; Merville P; Gandia P; Bouchet S; Le Meur Y; Petersen BS; Marquet P; Picard N, 2014, 'Pharmacogenetics of the calcineurin pathway and the risk of acute rejection in kidney transplant patients', in FUNDAMENTAL & CLINICAL PHARMACOLOGY, WILEY-BLACKWELL, pp. 41 - 41

Stojanova J; David A; Feuillard J; Zimber-Strobl U; Marquet P; Faumont N, 2013, 'LMP1-CD40 Mouse Model of Lymphoma: A New Model to Evaluate the Lymphomagenesis Potential of Immunosuppressants', in THERAPEUTIC DRUG MONITORING, LIPPINCOTT WILLIAMS & WILKINS, UT, Salt Lake City, pp. 694 - 695, presented at 13th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, UT, Salt Lake City, 22 September 2013 - 26 September 2013

Stojanova J; Caillard S; Rousseau A; Roussel H; Rerolle JP; Essig M; Marquet P, 2011, 'Pharmacological & pharmacogenetic factors in post-transplant lymphoproliferative disease: feasibility of matching in a case-control study', in THERAPEUTIC DRUG MONITORING, LIPPINCOTT WILLIAMS & WILKINS, GERMANY, Stuttgart, pp. 509 - 510, presented at 12th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, GERMANY, Stuttgart, 02 October 2011 - 06 October 2011

Stojanova J; Caillard S; Rousseau A; Roussel H; Rerolle J; Essig M; Marquet P, 2011, 'Pharmacological determinants of post-transplant lymphoproliferative disease (PTLD): feasibility of a large case-control study', in FUNDAMENTAL & CLINICAL PHARMACOLOGY, WILEY-BLACKWELL, pp. 65 - 66

Velizarova M; Popova D; Hadjiev E; Slavova M; Alexandrova K; Toshkov S; Stojanova J; Dimova I; Zaharieva B, 2004, 'Rare genetic aberrations in adult CD10+B-cell acute lymphoblastic leukemia (B-ALL)', in GENES AND IMMUNITY, NATURE PUBLISHING GROUP, BULGARIA, Sofia, pp. S48 - S48, presented at 18th European Histocompatibility Conference, BULGARIA, Sofia, 08 May 2004 - 11 May 2004

PRODANOV P; STOJANOVA J, 1984, 'COMPARATIVE QUANTITATIVE INVESTIGATIONS OF A1, B AND RH0(D) ERYTHROCYTE ANTIGENS IN NEWBORNS AND ADULTS', in BIOMEDICA BIOCHIMICA ACTA, AKADEMIE VERLAG GMBH, pp. S59 - S60

Back to profile page